Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 47 Leukemia 28 Prostatic Neoplasms 21 Burkitt Lymphoma 17 Leukemia, Biphenotypic, Acute 15 Lymphoma 13 Leukemia, Myeloid, Acute 7 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 6 Lymphoma, Large B-Cell, Diffuse 6 Recurrence 5 Lymphoma, Non-Hodgkin 5 Myelodysplastic Syndromes 4 Hodgkin Disease 4 Pituitary Neoplasms 3 Pancreatic Neoplasms 3 Neoplasms 3 Lymphoma, T-Cell 3 Lymphoma, Large-Cell, Immunoblastic 3 Lymphoma, Large-Cell, Anaplastic 3 Lymphoma, B-Cell 3 Dendritic Cell Sarcoma, Interdigitating 3 Breast Neoplasms 3 Anemia, Refractory, with Excess of Blasts 3 Rhabdoid Tumor 2 Polycystic Ovary Syndrome 2 Obesity 2 Multiple Myeloma 2 Lymphoma, Mantle-Cell 2 Lymphoma, Follicular 2 Leukemia, Myelomonocytic, Juvenile 2

Interventions

Pancreaticoduodenectomy 4 pasireotide 1 glubran 2 1 Serum Albumin, Human 1 Radiosurgery 1 Polygeline 1 Pancreaticojejunostomy 1 Neoprene 1 Laparotomy 1 Hydrocortisone 1 Anti-Bacterial Agents 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Pancreatic Fistula × Hydrocortisone × Clear all

NCT02775227 2020-08-24

HYPAR

Helsinki University Central Hospital

Phase 4 Active not recruiting

Gastrointestinal

Pancreatic Fistula, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡